BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25270271)

  • 1. Classics in chemical neuroscience: levodopa.
    Whitfield AC; Moore BT; Daniels RN
    ACS Chem Neurosci; 2014 Dec; 5(12):1192-7. PubMed ID: 25270271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
    Lees AJ; Tolosa E; Olanow CW
    Mov Disord; 2015 Jan; 30(1):19-36. PubMed ID: 25488030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medical treatment of Parkinson disease from James Parkinson to George Cotzias.
    Fahn S
    Mov Disord; 2015 Jan; 30(1):4-18. PubMed ID: 25491387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent.
    Hornykiewicz O
    Amino Acids; 2002; 23(1-3):65-70. PubMed ID: 12373520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Short history of L-Dopa].
    García Ruiz PJ; Meseguer E
    Neurologia; 2002 Apr; 17(4):214-7. PubMed ID: 11940409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics.
    LeWitt PA
    Mov Disord; 2015 Jan; 30(1):64-72. PubMed ID: 25449210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa/carbidopa/entacapone in Parkinson's disease.
    Seeberger LC; Hauser RA
    Expert Rev Neurother; 2009 Jul; 9(7):929-40. PubMed ID: 19589043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy in Parkinson's disease].
    van Hilten JJ; Roos RA
    Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Levodopa: the story continues].
    Titova NV; Katunina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):93-9. PubMed ID: 25473661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa in the early treatment of Parkinson's disease.
    Murata M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa ameliorated anorectal constipation in de novo Parkinson's disease: The QL-GAT study.
    Tateno F; Sakakibara R; Yokoi Y; Kishi M; Ogawa E; Uchiyama T; Yamamoto T; Yamanishi T; Takahashi O
    Parkinsonism Relat Disord; 2011 Nov; 17(9):662-6. PubMed ID: 21705259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease.
    Yokochi M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S25-30. PubMed ID: 19131038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-dopa therapy for Parkinson's disease: past, present, and future.
    Nagatsua T; Sawadab M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S3-8. PubMed ID: 19131039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.
    Fernandez HH; Odin P
    Curr Med Res Opin; 2011 May; 27(5):907-19. PubMed ID: 21351823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of levodopa and dopamine agonists in Parkinson's disease treatment.
    Tolosa E; Martí MJ; Valldeoriola F; Molinuevo JL
    Neurology; 1998 Jun; 50(6 Suppl 6):S2-10; discussion S44-8. PubMed ID: 9633679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The history of dopamine and levodopa in the treatment of Parkinson's disease.
    Fahn S
    Mov Disord; 2008; 23 Suppl 3():S497-508. PubMed ID: 18781671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa therapy for Parkinson disease: A look backward and forward.
    LeWitt PA; Fahn S
    Neurology; 2016 Apr; 86(14 Suppl 1):S3-12. PubMed ID: 27044648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?
    Mercuri NB; Bernardi G
    Trends Pharmacol Sci; 2005 Jul; 26(7):341-4. PubMed ID: 15936832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa in the treatment of Parkinson's disease: current status and new developments.
    Salat D; Tolosa E
    J Parkinsons Dis; 2013 Jan; 3(3):255-69. PubMed ID: 23948989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.
    Stocchi F; Rascol O; Kieburtz K; Poewe W; Jankovic J; Tolosa E; Barone P; Lang AE; Olanow CW
    Ann Neurol; 2010 Jul; 68(1):18-27. PubMed ID: 20582993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.